Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer.

J Ovarian Res · 2020 · PMC7442990 · PMID 32825834

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

Metformin before or during chemotherapy indeed showed a trend toward better overall survival compared with single chemotherapy, although this trend did not reach statistical significance ( Fig. 4 d).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.